Plasma levels of aminothiols, nitrite, nitrate, and malondialdehyde in myelodysplastic syndromes in the context of clinical outcomes and as a consequence of iron overload

Oxidative Medicine and Cellular Longevity

Volumn 2014, Issue , 2014, Pages

  Pimková, Kristýna ^a   Chrastinová, Leona ^a   Suttnar, Jiří ^a   Štikarová, Jana ^a   Kotlín, Roman ^a   Čermák, Jaroslav ^a   Dyr, Jan Evangelista ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINYLGLYCINE; DIPEPTIDE; FERRITIN; IRON; MALONALDEHYDE; NITRIC ACID DERIVATIVE; NITRITE; THIOL DERIVATIVE;

BLOOD; CASE CONTROL STUDY; COMPLICATION; HUMAN; IRON OVERLOAD; MYELODYSPLASTIC SYNDROME; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; TREATMENT OUTCOME;

CASE-CONTROL STUDIES; DIPEPTIDES; FERRITINS; HUMANS; IRON; IRON OVERLOAD; MALONDIALDEHYDE; MYELODYSPLASTIC SYNDROMES; NITRATES; NITRITES; OXIDATION-REDUCTION; OXIDATIVE STRESS; SULFHYDRYL COMPOUNDS; TREATMENT OUTCOME;

EID: 84893851488     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2014/416028     Document Type: Article

References (41)

1. Farquhar M. J., Bowen D. T., Oxidative stress and the myelodysplastic syndromes. International Journal of Hematology 2003 77 4 342 350 2-s2.0-0141680971 (Pubitemid 37121829)
2. Gattermann N., Rachmilewitz E. A., Iron overload in MDS-pathophysiology, diagnosis, and complications. Annals of Hematology 2011 90 1 1 10 2-s2.0-78651287827 10.1007/s00277-010-1091-1
3. Saigo K., Takenokuchi M., Hiramatsu Y., Tada H., Hishita T., Takata M., Misawa M., Imoto S., Imashuku S., Oxidative stress levels in myelodysplastic syndrome patients: their relationship to serum ferritin and haemoglobin values. Journal of International Medical Research 2011 39 5 1941 1945 2-s2.0-80155141156
4. Ghoti H., Amer J., Winder A., Rachmilewitz E., Fibach E., Oxidative stress in red blood cells, platelets and polymorphonuclear leukocytes from patients with myelodysplastic syndrome. European Journal of Haematology 2007 79 6 463 467 2-s2.0-36248937215 10.1111/j.1600-0609.2007.00972.x (Pubitemid 350126678)
5. Cortelezzi A., Cattaneo C., Cristiani S., Duca L., Sarina B., Deliliers G. L., Fiorelli G., Cappellini M. D., Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis? Hematology Journal 2000 1 3 153 158 2-s2.0-0034585292
6. Cortelezzi A., Fracchiolla N. S., Bamonti-Catena F., Motta M., Cighetti G., Carrabba M., Cavalca V., Maiolo A. T., Deliliers G. L., Hyperhomocysteinemia in myelodysplastic syndromes: specific association with autoimmunity and cardiovascular disease. Leukemia and Lymphoma 2001 41 1-2 147 150 2-s2.0-0035068044 (Pubitemid 32294197)
7. Peddie C. M., Wolf C. R., Mclellan L. I., Collins A. R., Bowen D. T., Oxidative DNA damage in CD34+ myelodysplastic cells is associated with intracellular redox changes and elevated plasma tumour necrosis factor- α concentration. British Journal of Haematology 1997 99 3 625 631 2-s2.0-0030664927 (Pubitemid 27519866)
8. Choi J. W., No significant correlation exists between nitric oxide production and apoptosis in myelodysplastic syndromes. Acta Haematologica 2003 109 1 50 52 2-s2.0-0037209305 10.1159/000067276 (Pubitemid 41754750)
9. Giustarini D., Dalle-Donne I., Tsikas D., Rossi R., Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Critical Reviews in Clinical Laboratory Sciences 2009 46 5-6 241 281
10. Raijmakers M. T. M., Steegers E. A. P., Peters W. H. M., Glutathione S-transferases and thiol concentrations in embryonic and early fetal tissues. Human Reproduction 2001 16 11 2445 2450 2-s2.0-0035152822 (Pubitemid 33054153)
11. Garcia A. J., Apitz-Castro R., Plasma total homocysteine quantification: an improvement of the classical high-performance liquid chromatographic method with fluorescence detection of the thiol-SBD derivatives. Journal of Chromatography B 2002 779 2 359 363 2-s2.0-0037027506 10.1016/S1570-0232(02) 00401-4 (Pubitemid 35279464)
12. Li H., Meininger C. J., Wu G., Rapid determination of nitrite by reversed-phase high-performance liquid chromatography with fluorescence detection. Journal of Chromatography B 2000 746 2 199 207 2-s2.0-0034666494 10.1016/S0378-4347(00)00328-5 (Pubitemid 30657936)
13. Woitzik J., Abromeit N., Schaefer F., Measurement of nitric oxide metabolites in brain microdialysates by a sensitive fluorometric high-performance liquid chromatography assay. Analytical Biochemistry 2001 289 1 10 17 2-s2.0-0035253387 10.1006/abio.2000.4893 (Pubitemid 32121563)
14. Davies C. A., Perrett D., Zhang Z., Nielsen B. R., Blake D. R., Winyard P. G., Simultaneous analysis of nitrite, nitrate and the nicotinamide nucleotides by capillary electrophoresis: application to biochemical studies and human extracellular fluids. Electrophoresis 1999 20 10 2111 2117 (Pubitemid 29376819)
15. Suttnar J., Mášová L., Dyr J. E., Influence of citrate and EDTA anticoagulants on plasma malondialdehyde concentrations estimated by high-performance liquid chromatography. Journal of Chromatography B 2001 751 1 193 197 2-s2.0-0035835379 10.1016/S0378-4347(00)00453-9 (Pubitemid 32146328)
16. Štikarová J., Suttnar J., Pimková K., Chrastinová-Má Ová L., Ermák J., Dyr J. E., Enhanced levels of asymmetric dimethylarginine in a serum of middle age patients with myelodysplastic syndrome. Journal of Hematology and Oncology 2013 6 1, article 58
17. Moshage H., Kok B., Huizenga J. R., Jansen P. L. M., Nitrite and nitrate determinations in plasma: a critical evaluation. Clinical Chemistry 1995 41 6 892 896 2-s2.0-0029033537
18. Kleinbongard P., Dejam A., Lauer T., Rassaf T., Schindler A., Picker O., Scheeren T., Gödecke A., Schrader J., Schulz R., Heusch G., Schaub G. A., Bryan N. S., Feelisch M., Kelm M., Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radical Biology and Medicine 2003 35 7 790 796 2-s2.0-10744229717 10.1016/S0891-5849(03)00406-4 (Pubitemid 37329482)
19. Lauer T., Preik M., Rassaf T., Strauer B. E., Deussen A., Feelisch M., Kelm M., Plasma nitrite rather than nitrate reflects regional endothelial nitric oxide synthase activity but lacks intrinsic vasodilator action. Proceedings of the National Academy of Sciences of the United States of America 2001 98 22 12814 12819 2-s2.0-0035940415 10.1073/pnas.221381098 (Pubitemid 33020027)
20. Alusik S., Jedlickova V., Paluch Z., Zecova S., Plasma levels of nitrite/nitrate and inflammation markers in elderly individuals. Bratislavské lekárske listy 2008 109 7 289 292 2-s2.0-53449085076
21. Mikiwa K., Tadashi I., Kayoko K., Plasma nitrate/nitrite concentration in healthy population and patients with diabetes mellitus: relationships with gender, aging and diabetic complications. Bulletin of the Osaka Medical College 2002 48 1 6
22. Bates C. J., Mansoor M. A., Gregory J., Pentieva K., Prentice A., Correlates of plasma homocysteine, cysteine and cysteinyl-glycine in respondents in the British National Diet and Nutrition Survey of young people aged 4-18 years, and a comparison with the survey of people aged 65 years and over. British Journal of Nutrition 2002 87 1 71 79 2-s2.0-0036165091 10.1079/BJN2001479 (Pubitemid 34116444)
23. Modun D., Krnic M., Vukovic J., Kokic V., Kukoc-Modun L., Tsikas D., Dujic Z., Plasma nitrite concentration decreases after hyperoxia-induced oxidative stress in healthy humans. Clinical Physiology and Functional Imaging 2012 32 5 404 408 2-s2.0-84859509939 10.1111/j.1475-097X.2012.01133.x
24. Vermeulen Windsant I. C., de Wit N. C., Sertorio J. T., Beckers E. A., Tanus-Santos J. E., Jacobs M. J., Buurman W. A., Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study. Critical Care 2012 16 3, article R95
25. Dreißigacker U., Suchy M.-T., Maassen N., Tsikas D., Human plasma concentrations of malondialdehyde (MDA) and the F2-isoprostane 15(S)-8-iso-PGF2 α may be markedly compromised by hemolysis: evidence by GC-MS/MS and potential analytical and biological ramifications. Clinical Biochemistry 2010 43 1-2 159 167 2-s2.0-72649106909 10.1016/j.clinbiochem.2009.10.002
26. Mayer B., Andrew P., Nitric oxide synthases: catalytic function and progress towards selective inhibition. Naunyn-Schmiedeberg's Archives of Pharmacology 1998 358 1 127 133 2-s2.0-0031844699 10.1007/PL00005233 (Pubitemid 28365969)
27. de Chiara B., Sedda V., Parolini M., Campolo J., de Maria R., Caruso R., Pizzi G., Disoteo O., Dellanoce C., Corno A. R., Cighetti G., Parodi O., Plasma total cysteine and cardiovascular risk burden: action and interaction. Scientific World Journal 2012 2012 303654 10.1100/2012/303654
28. Jacob N., Bruckert E., Giral P., Foglietti M. J., Turpin G., Cysteine is a cardiovascular risk factor in hyperlipidemic patients. Atherosclerosis 1999 146 1 53 59 2-s2.0-0032803930 10.1016/S0021-9150(99)00128-8 (Pubitemid 29371861)
29. Müller T., Muhlack S., Cysteinyl-glycine reduction as marker for levodopa-induced oxidative stress in Parkinson's disease patients. Movement Disorders 2011 26 3 543 546 2-s2.0-79953271910 10.1002/mds.23384
30. Passi S., Grandinetti M., Maggio F., Stancato A., De Luca C., Epidermal oxidative stress in vitiligo. Pigment Cell Research 1998 11 2 81 85 2-s2.0-0032042815 (Pubitemid 128532953)
31. De Chiara B., Mafrici A., Campolo J., Famoso G., Sedda V., Parolini M., Cighetti G., Lualdi A., Fiorentini C., Parodi O., Low plasma glutathione levels after reperfused acute myocardial infarction are associated with late cardiac events. Coronary Artery Disease 2007 18 2 77 82 2-s2.0-33847053246 10.1097/01.mca.0000236294.32672.26
32. Shimizu H., Kiyohara Y., Kato I., Kitazono T., Tanizaki Y., Kubo M., Ueno H., Ibayashi S., Fujishima M., Iida M., Relationship between plasma glutathione levels and cardiovascular disease in a defined population: the Hisayama study. Stroke 2004 35 9 2072 2077 2-s2.0-4344679570 10.1161/01.STR.0000138022.86509.2d (Pubitemid 39129563)
33. Hanigan M. H., Frierson H. F. Jr., Swanson P. E., De Young B. R., Altered expression of gamma-glutamyl transpeptidase in human tumors. Human Pathology 1999 30 3 300 305 2-s2.0-0033048835 (Pubitemid 29125150)
34. Raza A., Galili N., Smith S., Godwin J., Lancet J., Melchert M., Jones M., Keck J. G., Meng L., Brown G. L., List A., Phase 1 multicenter dose-escalation study of ezatiostat hydrochloride (TLK199 tablets), a novel glutathione analog prodrug, in patients with myelodysplastic syndrome. Blood 2009 113 26 6533 6540 2-s2.0-69249238115 10.1182/blood-2009-01-176032
35. Dickinson D. A., Forman H. J., Glutathione in defense and signaling: lessons from a small thiol. Annals of the New York Academy of Sciences 2002 973 488 504 2-s2.0-0036960604 (Pubitemid 36131049)
36. Tager M., Ittenson A., Franke A., Frey A., Gassen H. G., Ansorge S., γ -glutamyl transpepsidase-cellular expression in populations of normal human mononuclear cells and patients suffering from leukemias. Annals of Hematology 1995 70 5 237 242 2-s2.0-0028989695 10.1007/s002770050062
37. Proctor M. J., Talwar D., Balmar S. M., O'Reilly D. S. J., Foulis A. K., Horgan P. G., Morrison D. S., McMillan D. C., The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. British Journal of Cancer 2010 103 6 870 876 2-s2.0-77956423480 10.1038/sj.bjc.6605855
38. Diergaarde B., Brand R., Lamb J., Cheong S. Y., Stello K., Barmada M. M., Feingold E., Whitcomb D. C., Pooling-based genome-wide association study implicates gamma- glutamyltransferase 1 (GGT1) gene in pancreatic carcinogenesis. Pancreatology 2010 10 2-3 194 200 2-s2.0-77952317079 10.1159/000236023
39. de Donatis G. M., Moschini R., Cappiello M., del Corso A., Mura U., Cysteinyl-glycine in the control of glutathione homeostasis in bovine lenses. Molecular Vision 2010 16 1025 1033 2-s2.0-77955633215
40. Vasikova A., Belickova M., Budinska E., Cermak J., A distinct expression of various gene subsets in CD34+ cells from patients with early and advanced myelodysplastic syndrome. Leukemia Research 2010 34 12 1566 1572 2-s2.0-77957162079 10.1016/j.leukres.2010.02.021
41. Valent P., Krieger O., Stauder R., Wimazal F., Nösslinger T., Sperr W. R., Sill H., Bettelheim P., Pfeilstöcker M., Iron overload in myelodysplastic syndromes (MDS): diagnosis, management, and response criteria: A proposal of the Austrian MDS platform. European Journal of Clinical Investigation 2008 38 3 143 149 2-s2.0-38849199273 10.1111/j.1365-2362.2007. 01915.x (Pubitemid 351197091)